We know it's tough to keep track of all the different maternal and children's health foundations, coalitions, and initiatives, with tons out there and more cropping up every day. Each large scale partnership or initiative fills a niche, seeking to reduce maternal mortality through slightly different means. Maternova has put together a cheat-sheet on these newer campaigns and initiatives.
Postpartum depression (PPD) affects 1 in 7 new mothers and can lead to severe risks for both mother and baby if untreated. In 2019, the FDA approved Zulresso, a costly hospital-administered drug. Recently, the FDA approved Zurzuvae, the first oral PPD treatment, offering a more accessible and home-based option.